EDGAR Filing Documents for 0001873919-24-000004

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001873919-24-000004

Filing Date

2024-11-01

Accepted

2024-11-01 18:08:10

Documents

Period of Report

2024-10-30

Document Format Files

Seq	Description	Document	Type	Size
1	PRIMARY DOCUMENT	primary_doc.html	4
1	PRIMARY DOCUMENT	primary_doc.xml	4	14369
	Complete submission text file	0001873919-24-000004.txt		16376

Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494

Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445

Candel Therapeutics, Inc. (Issuer) CIK: 0001841387 (see all company filings)

IRS No.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494

Business Address

Aguilar Laura K. (Reporting) CIK: 0001873915 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 241420283

Mailing Address CANDEL THERAPEUTICS, INC. 117 KENDRICK ST SUITE 450 NEEDHAM MA 02494

Business Address

Aguilar-Cordova Estuardo (Reporting) CIK: 0001873919 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40629 | Film No.: 241420284